abstract |
The present invention contains the sequence RGD, for example, for the production of appropriately functionalized αvβ3 and αvβ5 integrin antagonists, or for the production of diagnostically useful compounds, for the treatment of degenerated angiogenesis phenomena. The present invention relates to a novel cyclic peptide-like compound. |